Human tissue kallikreins and testicular cancer

APMIS

Volumn 111, Issue 1, 2003, Pages 225-233

  Luo, Liu Ying ^a,b   Yousef, George ^a,b   Diamandis, Eleftherios P ^a,b   Looijenga, Leendert ^c   Bjartell, Anders ^c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE

Author keywords

Human tissue kallikreins; Prognostic markers; Splice variants; Testicular cancer; Tissue specific expression; Tumor markers

Indexed keywords

GLYCEROPHOSPHATE CALCIUM; HUMAN STRATUM CORNEUM CHYMOTRYPTIC ENZYME; KALLIKREIN; NEUROPSIN; PANCREATIC KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; TISSUE KALLIKREIN; UNCLASSIFIED DRUG;

CANCER PATIENT; CARCINOGENESIS; CONFERENCE PAPER; DOWN REGULATION; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENETIC ANALYSIS; HORMONAL REGULATION; HUMAN; KALLIKREIN 10 GENE; KALLIKREIN 13 GENE; KALLIKREIN 14 GENE; KALLIKREIN 5 GENE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; TESTIS CANCER; TISSUE;

CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 19; ENZYME ACTIVATION; HISTOCYTOCHEMISTRY; HUMANS; MALE; TESTICULAR NEOPLASMS; TISSUE KALLIKREINS;

EID: 0037884919     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2003.11101261.x     Document Type: Conference Paper

References (60)

1. Clements J. The molecular biology of the kallikreins and their roles in inflammation. In: Farmer S, editor. The Kinin System. San Diego, CA: Academic Press, 1997;5:71-97.
2. Yu H, Bowden DW, Spray BJ, Rich SS, Freedman BI. Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease. Hypertension 1998;31:906-11.
3. Bhoola K, Figueroa C, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1-80.
4. Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 2001;22:184-204.
5. Diamandis EP, Yousef GM, Clements J, Ashworth LK, Yoshida S, Egelrud T, Nelson PS, Shiosaka S, Little S, Lilja H, Stenman UH, Rittenhouse HG, Wain H. New nomenclature for the human tissue kallikrein gene family. Clin Chem 2000;46:1855-8.
6. Clements JA, Mukhtar A, Ehrlich A, Yap B. Kallikrein gene expression in the human uterus. Braz J Med Biol Res 1994;27:1855-63.
7. Riegman PH, Vlietstra RJ, van der Korput HA, Romijn JC, Trapman J. Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species. Mol Cell Endocrinol 1991;76:181-90.
8. Cleutjens KB, van der Korput HA, Ehren-van Eekelen CC, Sikes RA, Fasciana C, Chung LW, Trapman J. A 6-kb promoter fragment mimics in transgenic mice the prostate- specific and androgen-regulated expression of the endogenous prostate- specific antigen gene in humans. Mol Endocrinol 1997;11:1256-65.
9. Riegman PH, Vlietstra RJ, van der Korput JA, Brinkmann AO, Trapman J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 1991;5:1921-30.
10. Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW, Trapman J. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate- specific antigen promoter. Mol Endocrinol 1997;11:148-61.
11. Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG, Henderson DR. Prostate-specific antigen expression is regulated by an up-stream enhancer. J Biol Chem 1996;271:7043-51.
12. Huang W, Shostak Y, Tarr P, Sawyers C, Carey M. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J Biol Chem 1999;274:25756-68.
13. Murray SR, Chao J, Lin FK, Chao L. Kallikrein multigene families and the regulation of their expression. J Cardiovasc Pharmacol 1990;15:S7-16.
14. Maier M, Austen KF, Spragg J. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens. Proc Natl Acad Sci U S A 1983;80:3928-32.
15. Schedlich LJ, Bennetts BH, Morris BJ. Primary structure of a human glandular kallikrein gene. DNA 1987;6:429-37.
16. Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res 1997;57:3111-4.
17. Takayama TK, Fujikawa K, Davie EW. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J Biol Chem 1997;272:21582-8.
18. Lovgren J, Rajakoski K, Karp M, Lundwall A, Lilja H. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem Biophys Res Commun 1997;238:549-55.
19. Akiyama K, Nakamura T, Iwanaga S, Hara M. The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein. FEBS Lett 1987;225:168-72.
20. Lilja H. A kallikrein -like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76:1899-903.
21. Gomis-Ruth FX, Bayes A, Sotiropoulou G, Pampalakis G, Tsetsenis T, Villegas V, Aviles FX, Coll M. The structure of human kallikrein 6 reveals a novel activation mechanism for the kallikrein family. J Biol Chem 2002;16:16.
22. Bernett MJ, Blaber SI, Scarisbrick IA, Dhanarajan P, Thompson SM, Blaber M. Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J Biol Chem 2002;277:24562-70.
23. Shimizu C, Yoshida S, Shibata M, Kato K, Momota Y, Matsumoto K, Shiosaka T, Midorikawa R, Kamachi T, Kawabe A, Shiosaka S. Characterization of recombinant and brain neuropsin, a plasticity- related serine protease. J Biol Chem 1998;273:11189-96.
24. Yoshida S, Taniguchi M, Suemoto T, Oka T, He X, Shiosaka S. cDNA cloning and expression of a novel serine protease, TLSP. Biochim Biophys Acta 1998;1399:225-8.
25. Hansson L, Stromqvist M, Backman A, Wallbrandt P, Carlstein A, Egelrud T. Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J Biol Chem 1994;269:19420-6.
26. Tanimoto H, Underwood LJ, Shigemasa K, Yan Yan MS, Clarke J, Parmley TH, O'Brien TJ. The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer 1999;86:2074-82.
27. Yamashiro K, Tsuruoka N, Kodama S, Tsujimoto M, Yamamura Y, Tanaka T, Nakazato H, Yamaguchi N. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochimica et Biophysica Acta 1997;1350:11-4.
28. Little SP, Dixon EP, Norris F, Buckley GW, Johnson M, Dobbins JR, Wyrick T, Miller JR, Mackellar W, Hepburn D, Corvalan J, McClure D, Liu X, Stephenson D, Clements J, John-stone EM. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzeimer's disease brain. J biol Chem 1997;272:25135-42.
29. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 1998;35:275-368.
30. Magklara A, Scorilas A, Catalona WJ, Diamandis EP. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA. Clin Chem 1999;45:1960-6.
31. Pretlow TG, Pretlow TP, Yang B, Kaetzel CS, Delmoro CM, Kamis SM, Bodner, DR, Kursh E, Resnick MI, Bradley EL Jr. Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia. Int J Cancer 1991;49:645-9.
32. Magklara A, Scorilas A, Stephan C, Kristiansen GO, Hauptmann S, Jung K, Diamandis EP. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue. Urology 2000;56:527-32.
33. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJ, Levesque MA, Roagna R, Ponzone R, Sismondi P. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 1995c;55:2104-10.
34. Yousef GM, Diamandis EP. Kallikreins, steroid hormones and ovarian cancer: is there a link? Minerva Endocrinol 2002;27:157-66.
35. Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem 2002;48:1198-205.
36. Obiezu CV, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Rigault de la Longrais IA, Arisio R, Diamandis EP. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. Clin Cancer Res 2001;7:2380-6.
37. Dong Y, Kaushal A, Bui L, Chu S, Fuller PJ, Nicklin J, Samaratunga H, Clements JA. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin Cancer Res 2001;7:2363-71.
38. Kim H, Scorilas A, Katsaros D, Yousef GM, Massobrio M, Fracchioli S, Piccinno R, Gordini G, Diamandis EP. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer 2001;84:643-50.
39. Hoffman B, Katsaros D, Scorilas A, Diamandis P, Fracchioli S, Rigamlt de la Longrais IA, Colgan T, Pnopolo M, Giardina G, Massobrio M, Diamandis EP. Immunofluorometric quantitation and histochemical localization of kallikrein 6 protein in ovarain cancer tissue: a new independent unfavorable marker. Br J Cancer 2002;87(7):763-71.
40. Luo LY, Katsaros D, Scorilas A, Fracchioli S, Piccinno R, Rigault de la Longrais IA, Howarth DJ, Diamandis EP. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin Cancer Res 2001;7:2372-9.
41. Magklara A, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Danese S, Diamandis EP. The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer R es 2001;7:806-11.
42. Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: A new independent and favorable prognostic marker. Cancer Res 2001;61:7811-8.
43. Yousef GM, Scorilas A, Fracchioli S, Borgono CA, Iskander L, Richiardi G, Massobrio M, Katsaros D, Diamandis EP. Steroid hormone regulation and prognostic value of human kallikrein gene 14 (KLK14) in ovarian cancer. Amer J Clin Pathol 2003;in press.
44. Luo LY, Bunting P, Scorilas A, Diamandis EP. Human kallikrein 10: a novel tumor marker for ovarian carcinoma? Clin Chim Acta 2001;306:111-8.
45. Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin Biochem 2000;33:579-83.
46. Diamandis EP, Okui A, Mitsui S, Luo LY, Soosaipillai A, Grass L, Nakamura T, Howarth DJC, Yamaguchi N. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res 2002;62(1):295-300.
47. Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med 1996;2:624-36.
48. Dhar S, Bhargava R, Yunes M, Li B, Goyal J, Naber SP, Wazer DE, Band V. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin Cancer Res 2001;7:3393-8.
49. Chang A, Yousef GM, Scorilas A, Grass L, Sismondi P, Ponzone R, Diamandis E P. Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer. Br J Cancer 2002;86:1457-64.
50. Yousef GM, Obiezu C, Jung K, Stephan C, Scorilas A, Diamandis EP. Differential expression of kallikrein gene 5 (KLK5) in cancerous and normal testicular tissues. Urology 2002;60(4):714-8.
51. Luo LY, Rajpert-De Meyts ER, Jung K, Diamandis EP. Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Br J Cancer 2001;85:220-4.
52. Chang A, Yousef GM, Jung K, Rajpert-De Meyts E, Diamandis EP. Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in the human testis and testicular cancer. Anticancer Res 2001;21:3147-52.
53. Yousef GM, Magklara A, Chang A, Jung K, Katsaros D, Diamandis EP. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res 2001;61:3425-31.
54. Kierszenbaum AL. Mammalian spermatogenesis in vivo and in vitro: a partnership of spermatogenic and somatic cell lineages. Endocr Rev 1994;15:116-34.
55. Goyal J, Smith KM, Cowan JM, Wazer DE, Lee SW, Band V. The role for NES1 serine protease as a novel tumor suppressor. Cancer Res 1998;58:4782-6.
56. Li B, Goyal J, Dhar S, Dimri G, Evron E, Sukumar S, Wazer DE, Band V. CpG methylation as a basis for breast tumor-specific loss of NES1/ kallikrein 10 expression. Cancer Res 2001;61:8014-21.
57. Yousef GM, Grass L, Polymeris M-E, Soosaipillai A, Chan P-C, Scorilas A, Borgono C, Harbeck N, Schmalfeldt B, Dorn J, Schmitt M, Diamandis EP. Human kallikrein 5 (hK5): a novel serum biomarker for breast and ovarian cancer. Cancer Res 2002;in press.
58. Luo LY, Grass L, Howarth DJ, Thibault P, Ong H, Diamandis EP. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Clin Chem 2001;47:237-46.
59. Kapadia C, Chang A, Sotiropoulou G, Yousef GM, Grass L, Soosaipillai A, Xing X, Howarth DHC, Diamandis EP. Human kallikrein 13: production and purification of recombinant protein, monoclonal and polyclonal antibodies and development of a sensitive and specific immunofluorometric assay. Clin Chem 2003;49:77-86.
60. Slawin KM, Shariat SF, Nguyen C, Leventis AK, Song W, Kattan MW, Young CY, Tindall DJ, Wheeler TM. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein. Cancer Res 2000;60:7142-8.